Multinational pharmaceutical company Aspen Pharmacare Holdings on Monday completed its secondary listing on A2X Markets.
The company retains its primary listing on the JSE.
“We continually strive for ways to increase value for our shareholders and A2X offers complementary investor trading benefits, while providing the prospect of increasing our shareholder base,” said group CE Stephen Saad.
To date, 18 companies with a combined market capitalisation of around R2.2-trillion, have listed on A2X.